Aurora

Device Medtronic, Inc.
Total Payments
$4.1M
Transactions
1,390
Doctors
17
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2023 $4.1M 1,390 17

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $4.1M 1,389 100.0%
Consulting Fee $280.00 1 0.0%

Payments by Type

Research
$4.1M
1,389 transactions
General
$280.00
1 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
PSR-CVG Medtronic, Inc. $3.9M 12
EV ICD CA Medtronic, Inc. $219,227 3
EV ICD Pilot Medtronic, Inc. $3,768 5

Top Doctors Receiving Payments for Aurora

Doctor Specialty Location Total Records
Unknown Lansing, MI $4.0M 1,219
, MD Internal Medicine Minneapolis, MN $43,772 30
, M.D Cardiovascular Disease Newport News, VA $30,591 29
, M.D Clinical Cardiac Electrophysiology Columbus, GA $23,748 32
, M.D Advanced Heart Failure and Transplant Cardiology Worcester, MA $6,375 21
, MD Cardiovascular Disease Columbus, OH $4,830 19
, M.D Cardiovascular Disease Madison, WI $3,097 7
, MD Cardiovascular Disease Grand Rapids, MI $3,063 12
, MD Clinical Cardiac Electrophysiology Santa Barbara, CA $2,201 3
, MD Neurological Surgery Great Neck, NY $1,490 1
, MD PHD Internal Medicine Boston, MA $1,020 1
, MD Internal Medicine Evanston, IL $750.00 2
, MD Cardiovascular Disease Huntington, NY $720.00 4
, MD Internal Medicine Dallas, TX $675.00 1
, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Los Angeles, CA $408.75 4
, MD Urology Coralville, IA $390.00 1
, MB CHB Cardiovascular Disease Lebanon, NH $361.00 3
, DNP Clinical Cardiac Electrophysiology Colorado Springs, CO $280.00 1

About Aurora

Aurora is a device associated with $4.1M in payments to 17 healthcare providers, recorded across 1,390 transactions in the CMS Open Payments database. The primary manufacturer is Medtronic, Inc..

Payment data is available from 2023 to 2023. In 2023, $4.1M was paid across 1,390 transactions to 17 doctors.

The most common payment nature for Aurora is "Unspecified" ($4.1M, 100.0% of total).

Aurora is associated with 3 research studies, including "PSR-CVG" ($3.9M).